Press ENTER, to search
Close

Early detected inherited diseases and genetic disorders.

Preimplantation genetic screening (PGS) with next generation sequencing (NGS)

Preimplantation genetic screening (PGS) with next generation sequencing (NGS) is the newest technique used to detect abnormal number of chromosomes from a single cell.

PGS NGS is advised to patients of advanced age who have a history of recurrent failed implantations and miscarriages. It is also indicated in patients with severe male infertility factor, e.g. if their sperm is of very poor quality.

Most recent studies prove that PGS increases the chance for getting pregnant in 55-70% of cases.

How does PGS NGS look like?

The test is performed on embryos during an in vitro cycle.

  • Embryo biopsy

Embryos are collected in 72-76 hours after fertilisation when they consist of 6-8 cells. This technique needs to be highly precise and is carried out by the most experienced embryologists. After biopsy embryos are placed back into the incubator so that they can develop further.

An embryo cell biopsy does not affect the normal development of the embryo. The risk of ceased development after biopsy is 0.53%.

  • Genetic testing

Cell obtained during biopsy are prepared for analysis and undergo genetic testing.

  • Embryo transfer

The transfer takes place immediately after receiving the results of genetic analysis, usually 4 or 5 days after collecting oocytes (puncture).

Contact us today

Confidentiality is our priority

A consent to marketing contact more: You have to choose more options (min ${minimumContactAgree})

Basic information regarding the processing of personal data

Basic information regarding the processing of personal data Data controller: Medi Partner Sp. z o. o, ul. Cybernetyki 19, 02-677 Warsaw/ Purpose of processing: marketing of own products and services [including profiling], marketing of Medicover Polska* products and services [including profiling] /Legal basis for processing: Your consent/ Recipients of data: Entities processing personal data on behalf of Medi Partner Sp. z o.o. / Rights with regard to the processing of data: the right to withdraw consent to the processing of personal data, right of access to personal data, other rights, as referred to in the detailed information on processing.

Contact us today

Confidentiality is our priority

An error occurred. Please try again later.

A consent to marketing contact more: You have to choose more options (min ${minimumContactAgree})

Basic information regarding the processing of personal data

Basic information regarding the processing of personal data Data controller: Medi Partner Sp. z o. o, ul. Cybernetyki 19, 02-677 Warsaw/ Purpose of processing: marketing of own products and services [including profiling], marketing of Medicover Polska* products and services [including profiling] /Legal basis for processing: Your consent/ Recipients of data: Entities processing personal data on behalf of Medi Partner Sp. z o.o. / Rights with regard to the processing of data: the right to withdraw consent to the processing of personal data, right of access to personal data, other rights, as referred to in the detailed information on processing.